பெஞ்சமின் எபர்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெஞ்சமின் எபர்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெஞ்சமின் எபர்ட் Today - Breaking & Trending Today

Kungl. Vetenskapsakademien: New knowledge about a cancer pharmaceutical led to the Sjöberg Prize


Kungl. Vetenskapsakademien: New knowledge about a cancer pharmaceutical led to the Sjöberg Prize
MALMÖ, Sweden, Feb. 15, 2021 /PRNewswire/
Benjamin L. Ebert, USA, receives this year s Sjöberg Prize, worth one million US dollars, for his research into how lenalidomide works as a treatment for blood cancer. His discovery of the mechanism that promotes protein breakdown in cancer cells may be vitally important to the future development of new pharmaceuticals.
The story of this pharmaceutical begins with a tragedy as, in the 1950s and 1960s, pregnant women with severe morning sickness were sometimes given thalidomide. This caused a range of birth defects and the medication was removed from the market. ....

United States , Hong Kong , Harvard University , Dana Farber Cancer Institute , Vastra Gotalands Lan , Maria Masucci , Kostenloser Wertpapierhandel , Benjaminl Ebert , Eva Nevelius , Benjamin Ebert , Prnewswire Benjaminl Ebert , Eva Hellstr , Harvard Stem Cell Institute , Harvard Medical School , Royal Swedish Academy Of Sciences , Prize Committee , Oxford University , Bengt Westermark , Harvard Stem Cell , Royal Swedish Academy , Sj 246 Berg , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , ஹார்வர்ட் பல்கலைக்கழகம் , டானா ஃபார்‌பர் புற்றுநோய் நிறுவனம் , பெஞ்சமின் எபர்ட் ,

Dana-Farber Medical Oncology Chair receives Sjöberg Prize for cancer research


Date Time
Dana-Farber Medical Oncology Chair receives Sjöberg Prize for cancer research
Benjamin Ebert, MD, PhD, Chair of Medical Oncology at Dana-Farber Cancer Institute, George P. Canellos, MD, and Jean S. Canellos Professor of Medicine at Harvard Medical School, and Institute Member of Broad Institute of Harvard and MIT, has been awarded the Sjöberg Prize, an annual international prize in cancer research. The prize was awarded for Dr. Ebert’s discovery of the mode of action of lenalidomide in the treatment of hematological disorders.
This is the fifth time that the Sjöberg Prize will be awarded. The Royal Swedish Academy of Sciences selects the laureates and the Sjöberg Foundation provides the financing. The prize amounts to one million dollars, of which $100,000 is the prize sum and $900,000 is funding for future research. ....

United States , Dana Farber Cancer Institute , Williams College , Georgep Canellos , Peter Ratcliffe , Benjamin Ebert , International Society Of Experimental Hematopoiesis , Investigator Of The Howard Hughes Medical Institute , American Society For Clinical Investigation , Harvard Medical School , Institute Member Of Broad Harvard , Royal Swedish Academy Of Sciences , National Academy Of Medicine , American Society Of Hematology , Prize Committee , Oncology At Dana Farber Cancer Institute , Oxford University , Association Of American Physicians , Medical Oncology , Institute Member , Broad Institute , Royal Swedish Academy , Howard Hughes Medical Institute , National Academy , American Society , Clinical Investigation ,

Scientists create ON-OFF switches to control CAR T cell activity


CAR T cells are a breakthrough class of effective but often toxic cancer therapies
To prevent overactivation, switchable CAR T cells were engineered that can be turned on and off with an approved, widely used cancer drug
BOSTON - Scientists at Dana-Farber Cancer Institute and Mass General Cancer Center have created molecular ON-OFF switches to regulate the activity of CAR T cells, a potent form of cell-based immunotherapy that has had dramatic success in treating some advanced cancers, but which pose a significant risk of toxic side effects.
CAR T cells are immune cells genetically modified to recognize and attack tumors cells. Once given, these living drugs proliferate and kill tumor cells over weeks to months, in some cases causing life-threatening inflammatory reactions that are difficult to control. In this way, CAR T cells are unlike more established forms of cancer therapy - chemotherapy or radiotherapy for instance - whose dose can be precisely tuned up or d ....

United States , Dana Farber Cancer Institute , Marcela Maus , Edwardp Evans , Benjamin Ebert , Max Jan , Broad Institute , National Institutes Of Health , Cancer Center , Harvard Medical School , Lymphoma Society , Scientists At Dana Farber Cancer Institute , Howard Hughes Medical Institute , Mass General Cancer Center , Science Translational Medicine , Harvard Medical , Medical Oncology , National Institutes , ஒன்றுபட்டது மாநிலங்களில் , டானா ஃபார்‌பர் புற்றுநோய் நிறுவனம் , மார்செலா மாயஸ் , பெஞ்சமின் எபர்ட் , அதிகபட்சம் ஜான் , பரந்த நிறுவனம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , புற்றுநோய் மையம் ,